751 studies found for:    "Hypercholesterolemia"
Show Display Options
Rank Status Study
21 Completed Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
22 Completed An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
23 Recruiting Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia
Conditions: Hypercholesterolemia;   Hyperlipoproteinemia Type II
Interventions: Drug: AEM-28;   Drug: Normal Saline
24 Completed Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia
Conditions: Hypercholesterolemia;   Cardiovascular Disease
Intervention: Drug: Plantago ovata husk
25 Completed Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States
Condition: Hypercholesterolemia
Intervention:
26 Completed STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)
Conditions: Hypertension;   Hypercholesterolemia
Intervention: Other: Treatment algorithm:caduet, Amlodipine, ACEI-ARB combo dose, a-blocker, b-blocker or spironolactone, dyslipidemic therapy with ezetamide
27 Completed A Study on the Effects of Soy Protein on Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Soy protein; 25 grams/day;   Dietary Supplement: Control protein
28 Completed A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia
Conditions: Essential Hypertension;   Hypercholesterolemia
Interventions: Drug: simvastatin;   Drug: valsartan
29 Active, not recruiting Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Condition: Familial Hypercholesterolemia
Intervention: Drug: lomitapide
30 Terminated Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: Placebo
31 Completed The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia
Conditions: Dyslipidemia;   Cardiovascular Disease;   Hypercholesterolemia
Interventions: Drug: Atorvastatin (Lipinon);   Drug: Atorvastatin (Lipitor)
32 Terminated Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: placebo
33 Terminated Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: atorvastatin;   Drug: placebo
34 Completed A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
Conditions: Hypertension;   Hypercholesterolemia
Intervention: Drug: valsartan + simvastatin
35 Completed
Has Results
Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
Conditions: Hypercholesterolemia;   Dyslipidemias
Intervention: Drug: Pitavastatin
36 Completed Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: LGT209;   Drug: Placebo
37 Completed Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin;   Drug: Simvastatin
38 Completed An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)
Condition: Hypercholesterolemia
Intervention: Drug: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 14 weeks
39 Completed Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia
Conditions: Mixed Dyslipidemia;   Hypercholesterolemia
Intervention: Drug: Fluvastatin
40 Completed A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)
Condition: Hypercholesterolemia
Interventions: Drug: MK0653A, ezetimibe (+) simvastatin;   Drug: Comparators: simvastatin and ezetimibe

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years